Just Other Articles

Perfection serves no one but itself. Or as Voltaire put it, "The best is the enemy of the good."

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

Extremes rarely work to the health and benefit of those striving for it or the goals they strive fo

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

r. This is one of the common blocks to success. If you can't move on to the next phase or stage in yo

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ur project until the one you are working on now is perfect, you may never move on. In that, good is not

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

served. And so the perfectionist creates his/her own dilemma.

I have heard speakers spend so much ti

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e defining words and terms they want to use in their speech and in such exacting detail, the point of t

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

he speech is lost.

Industry is full of stories of research and development teams attempting to make th

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

e product they are producing so perfect that by the time it gets to market, the product is obsolete. H

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ow do you balance "good enough to function" against "so bad it won't work"?

The way out of or through

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

dilemmas is to find and accept a third answer or another option in addition to the two "Either Or" opti

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ns which constitute the horns of the dilemma on which one is hung up. In the case of "Either perfect o

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

r Not at all" the third option is to get comfortable with mediocrity. Mediocre is not

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

best or worst but middle of the road. It is commonplace. Although it may feel like a compromise, it w

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ill release the struggler who says "Perfect or Bust" and get things moving again.

I am not against per

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

fection and striving for the best. I am offering a solution for the occasions when progress toward a

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

esired goal is arrested by the compulsive need to be perfect. As some have said, "Stability exists whe

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

n we work for progress, not perfection."

A final thought: after this perfect mountain is climbed, ther

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

e is another, higher, more perfect mountain behind that, and then another beyond that and then another.

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

... What a wonderful way to lose control of your life. Enough never becomes enough. Pursuit becomes t

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

he game and living in the moment long enough to enjoy what has been gained in the pursuit never happens

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/35147/justotherarticles-Not-Making-Progress-You-May-Be-Trying-Too-Hard.html">Not Making Progress? You May Be Trying Too Hard</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/35147/justotherarticles-Not-Making-Progress-You-May-Be-Trying-Too-Hard.html]Not Making Progress? You May Be Trying Too Hard[/url]

When doing medical billing, the enteral and parental CMNs are nearly identical. The main difference is the methods of feeding. In this installment, we cover the GP0 record, fields 8 through 14.

At the end of the third job interview, Helene was told by the hiring manager, “Congratulations, I am going to recommend you for the position. Expect a call from HR.” Helene breathed a sigh of relief ...

Tags

Links

Just Other Articles - Not Making Progress? You May Be Trying Too Hard

Related Articles: